Seoul, June 4 (IANS) South Korea’s exports of pharmaceutical products reached an all-time high in the first quarter thanks to strong demand for Korean medicines in the European market, according to a report on Wednesday.
Outbound shipments of pharmaceuticals came to a quarterly high of US$2.56 billion in the January-March period, up 17.7 per cent from a year earlier, according to data compiled by the Korea Health Industry Development Institute, Yonhap news agency reported.
In particular, shipments of biopharmaceutical products increased by 30.2 per cent year-over-year, driven by sharp rises in shipments to Germany and Hungary, which rose 230 per cent and 112 per cent year-over-year, respectively.
Vaccine exports also escalated 37.7 per cent on high demand in South America and Africa.
Meanwhile, outbound shipments of cosmetic products jumped 12.7 per cent on-year to $2.58 billion in the first three months of the year, marking the second-highest figure for any quarter, according to the institute.
“Strong demand for biopharmaceutical and basic skincare products is expected to continue into the second quarter,” it said.
The institute, however, noted there may be risks deriving from trade uncertainties sparked by US tariff policies.
US President Donald Trump has threatened to slap tariffs on foreign pharmaceutical products following already imposed duties on imports of steel, automobiles, and other key items.
South Korea has been seeking to gain a full exemption or reduction of the Trump administration’s 25 per cent reciprocal tariffs for the country, as well as sectoral tariffs on steel, automobile, and other imports.
In a working-level meeting in May, the office of the US Trade Representative (USTR) urged Seoul to resolve non-trade barrier issues listed on its 2025 National Trade Estimate (NTE) Report on Foreign Trade Barriers, a Seoul trade official has said on the condition of anonymity.
The NTE report had laid out a wide range of Korea’s non-tariff measures, including its import ban on American beef from cattle aged 30 months or older, South Korea’s “offset” defense trade policy, digital trade barriers, such as restrictions on the export of location-based data, and emission-related regulations on imported cars, as well as pricing policies for pharmaceuticals.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
